Prescription Drugs Monograph

  • Value for Money from the Top 20? A Critical Examination of Therapeutic Impact and Value of Top–Selling Drug Products against their Competitors
  • By Alan Cassels
  • Complete Paper
  •  
  • Managing the Pharmacy Benefit Impacts to Pharmacy Trend
  • By Bela Gorman, Laurie Doran and Jennifer Smagula
  • Complete Paper
  •  
  • State of Utah Children's Health Insurance Program (CHIP) Five–Year Pharmacy Analysis
  • By Dennis Kunimura
  • Complete Paper
  •  
  • The Formulary Decision Process: What Are They Doing in There and Can Actuaries Help?
  • By Jill Van Den Bos, M.A., John Watkins, R.Ph., MPH, Kristin Reed, MPH and Jonathan Shreve, FSA
  • Complete Paper
  •